Cargando…
Clinical Features, Survival and Prognostic Factors of Glycogen-Rich Clear Cell Carcinoma (GRCC) of the Breast in the U.S. Population
The World Health Organization (WHO) defines glycogen-rich clear cell carcinoma (GRCC) of the breast as a carcinoma with glycogen accumulation in more than 90% of its tumor cells. Due to the rarity of this disease, its reported survival and clinical associations have been inconsistent due to reliance...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406344/ https://www.ncbi.nlm.nih.gov/pubmed/30769905 http://dx.doi.org/10.3390/jcm8020246 |
_version_ | 1783401279700074496 |
---|---|
author | Zhou, Zhengqiu Kinslow, Connor J. Hibshoosh, Hanina Guo, Hua Cheng, Simon K. He, Chunyan Gentry, Matthew S. Sun, Ramon C. |
author_facet | Zhou, Zhengqiu Kinslow, Connor J. Hibshoosh, Hanina Guo, Hua Cheng, Simon K. He, Chunyan Gentry, Matthew S. Sun, Ramon C. |
author_sort | Zhou, Zhengqiu |
collection | PubMed |
description | The World Health Organization (WHO) defines glycogen-rich clear cell carcinoma (GRCC) of the breast as a carcinoma with glycogen accumulation in more than 90% of its tumor cells. Due to the rarity of this disease, its reported survival and clinical associations have been inconsistent due to reliance on case reports and limited case series. As a result, the prognostic implication of this cancer subtype remains unclear. Using the U.S. Surveillance, Epidemiology, and End Results (SEER) program database, we compared the incidence, demographics and prognostic factors of 155 cases of GRCC of the breast to 1,251,584 cases of other (non-GRCC) breast carcinomas. We demonstrate that GRCC is more likely to be identified as high grade, advanced stage, and more likely to have triple negative receptor status. GRCC cases display a poorer prognosis than non-GRCC carcinomas of the breast irrespective of age, AJCC staging, tumor grade, joint hormone receptor/human epidermal growth factor receptor 2 (HER2) status, and treatment. Similar to non-GRCC carcinomas, older age and higher American Joint Committee on Cancer (AJCC)/TNM staging were associated with poorer prognosis for GRCC, while treatment with surgery and radiation were associated with improved survival. Radiation, specifically in the setting of breast-conserving surgery, further improved survival compared to surgery alone. Our study highlights the poorer prognosis associated with glycogen accumulation in breast cancers and hence stresses the importance of identifying this more aggressive tumor type. |
format | Online Article Text |
id | pubmed-6406344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64063442019-03-22 Clinical Features, Survival and Prognostic Factors of Glycogen-Rich Clear Cell Carcinoma (GRCC) of the Breast in the U.S. Population Zhou, Zhengqiu Kinslow, Connor J. Hibshoosh, Hanina Guo, Hua Cheng, Simon K. He, Chunyan Gentry, Matthew S. Sun, Ramon C. J Clin Med Article The World Health Organization (WHO) defines glycogen-rich clear cell carcinoma (GRCC) of the breast as a carcinoma with glycogen accumulation in more than 90% of its tumor cells. Due to the rarity of this disease, its reported survival and clinical associations have been inconsistent due to reliance on case reports and limited case series. As a result, the prognostic implication of this cancer subtype remains unclear. Using the U.S. Surveillance, Epidemiology, and End Results (SEER) program database, we compared the incidence, demographics and prognostic factors of 155 cases of GRCC of the breast to 1,251,584 cases of other (non-GRCC) breast carcinomas. We demonstrate that GRCC is more likely to be identified as high grade, advanced stage, and more likely to have triple negative receptor status. GRCC cases display a poorer prognosis than non-GRCC carcinomas of the breast irrespective of age, AJCC staging, tumor grade, joint hormone receptor/human epidermal growth factor receptor 2 (HER2) status, and treatment. Similar to non-GRCC carcinomas, older age and higher American Joint Committee on Cancer (AJCC)/TNM staging were associated with poorer prognosis for GRCC, while treatment with surgery and radiation were associated with improved survival. Radiation, specifically in the setting of breast-conserving surgery, further improved survival compared to surgery alone. Our study highlights the poorer prognosis associated with glycogen accumulation in breast cancers and hence stresses the importance of identifying this more aggressive tumor type. MDPI 2019-02-14 /pmc/articles/PMC6406344/ /pubmed/30769905 http://dx.doi.org/10.3390/jcm8020246 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhou, Zhengqiu Kinslow, Connor J. Hibshoosh, Hanina Guo, Hua Cheng, Simon K. He, Chunyan Gentry, Matthew S. Sun, Ramon C. Clinical Features, Survival and Prognostic Factors of Glycogen-Rich Clear Cell Carcinoma (GRCC) of the Breast in the U.S. Population |
title | Clinical Features, Survival and Prognostic Factors of Glycogen-Rich Clear Cell Carcinoma (GRCC) of the Breast in the U.S. Population |
title_full | Clinical Features, Survival and Prognostic Factors of Glycogen-Rich Clear Cell Carcinoma (GRCC) of the Breast in the U.S. Population |
title_fullStr | Clinical Features, Survival and Prognostic Factors of Glycogen-Rich Clear Cell Carcinoma (GRCC) of the Breast in the U.S. Population |
title_full_unstemmed | Clinical Features, Survival and Prognostic Factors of Glycogen-Rich Clear Cell Carcinoma (GRCC) of the Breast in the U.S. Population |
title_short | Clinical Features, Survival and Prognostic Factors of Glycogen-Rich Clear Cell Carcinoma (GRCC) of the Breast in the U.S. Population |
title_sort | clinical features, survival and prognostic factors of glycogen-rich clear cell carcinoma (grcc) of the breast in the u.s. population |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406344/ https://www.ncbi.nlm.nih.gov/pubmed/30769905 http://dx.doi.org/10.3390/jcm8020246 |
work_keys_str_mv | AT zhouzhengqiu clinicalfeaturessurvivalandprognosticfactorsofglycogenrichclearcellcarcinomagrccofthebreastintheuspopulation AT kinslowconnorj clinicalfeaturessurvivalandprognosticfactorsofglycogenrichclearcellcarcinomagrccofthebreastintheuspopulation AT hibshooshhanina clinicalfeaturessurvivalandprognosticfactorsofglycogenrichclearcellcarcinomagrccofthebreastintheuspopulation AT guohua clinicalfeaturessurvivalandprognosticfactorsofglycogenrichclearcellcarcinomagrccofthebreastintheuspopulation AT chengsimonk clinicalfeaturessurvivalandprognosticfactorsofglycogenrichclearcellcarcinomagrccofthebreastintheuspopulation AT hechunyan clinicalfeaturessurvivalandprognosticfactorsofglycogenrichclearcellcarcinomagrccofthebreastintheuspopulation AT gentrymatthews clinicalfeaturessurvivalandprognosticfactorsofglycogenrichclearcellcarcinomagrccofthebreastintheuspopulation AT sunramonc clinicalfeaturessurvivalandprognosticfactorsofglycogenrichclearcellcarcinomagrccofthebreastintheuspopulation |